Raising an isolated low HDL-C level: Why, how, and when?

Michael Miller, MD
Director, Center for Preventive Cardiology, Department of Medicine and Epidemiology, University of Maryland Medical Center, Baltimore

Address: Michael Miller, MD, Director, Center for Preventive Cardiology, Department of Medicine and Epidemiology, University of Maryland Medical Center, 22 South Greene St., Room 53B06, Baltimore, MD 21201; e-mail: [email protected]

The author has indicated that he has received grant or research support from the Merck, Pfizer, Kos Pharmaceuticals, and AstraZeneca corporations.

Michael Miller, MD
Director, Center for Preventive Cardiology, Department of Medicine and Epidemiology, University of Maryland Medical Center, Baltimore

Address: Michael Miller, MD, Director, Center for Preventive Cardiology, Department of Medicine and Epidemiology, University of Maryland Medical Center, 22 South Greene St., Room 53B06, Baltimore, MD 21201; e-mail: [email protected]

The author has indicated that he has received grant or research support from the Merck, Pfizer, Kos Pharmaceuticals, and AstraZeneca corporations.

Michael Miller, MD
Director, Center for Preventive Cardiology, Department of Medicine and Epidemiology, University of Maryland Medical Center, Baltimore

Address: Michael Miller, MD, Director, Center for Preventive Cardiology, Department of Medicine and Epidemiology, University of Maryland Medical Center, 22 South Greene St., Room 53B06, Baltimore, MD 21201; e-mail: [email protected]

The author has indicated that he has received grant or research support from the Merck, Pfizer, Kos Pharmaceuticals, and AstraZeneca corporations.